2008至2017年欧洲侵袭性脑膜炎球菌病流行病学演变
该研究基于欧洲疾病预防控制中心监测数据,分析2008至2017年欧洲各国侵袭性脑膜炎球菌病(IMD)报告病例数与发病率。整体IMD发病率下降34.4%,B群仍占主导但十年间下降56.1%且近年降速放缓,W群和Y群发病率分别上升超过500%和130%,全血清群分析显示老年人群发病率上升。
要点
- 2008至2017年欧洲IMD整体发病率下降34.4%。
- B群仍为主导血清群,十年间下降56.1%,但近年降速放缓且随年龄组而异。
- W群和Y群发病率分别上升超过500%和130%,达0.10和0.07/10万。
核心结论
- 尽管2008至2017年欧洲IMD整体发病率下降,但观察到W群和Y群发病率上升,全血清群分析显示老年人群发病率上升。
- 作者认为可能需要调整现行疫苗接种策略以反映流行病学变化及其可能的未来演变。
研究设计与样本
- 研究从欧洲疾病预防控制中心传染病监测图谱中提取欧洲各国报告的IMD病例数及相关发病率。
- 按血清群和年龄组分析流行病学及其演变。
主要发现
- 2008至2017年间整体IMD发病率下降34.4%。
- 2017年B群仍占主导,十年间下降56.1%,但近年降速放缓且随年龄组而异。
- C群在2016年前为第二常见血清群,在1至24岁人群(MenC疫苗接种活动主要目标人群)中发病率下降,但在其他年龄组出现上升。
- 2008至2017年间W群和Y群发病率分别上升超过500%和超过130%,达到0.10/10万和0.07/10万。
- 全血清群分析显示随年龄组的演变趋势发生明显改变,发病率上升主要影响较年长年龄组。
临床怎么用
- 作者认为可能需要调整现行疫苗接种策略以反映流行病学变化及其可能的未来演变。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundInvasive meningococcal disease (IMD) epidemiology has fluctuated over the past 25 years and varies among serogroups, age groups and geographical locations.AimThis study analysed the evolution of European IMD epidemiology from 2008 to 2017 to identify trends.MethodsReported number of IMD cases and associated incidence were extracted from the European Centre for Disease Prevention and Control Surveillance Atlas for Infectious Diseases for individual European countries. Epidemiology and its evolution were analysed by serogroup and age group.ResultsOverall IMD incidence decreased by 34.4% between 2008 and 2017. Serogroup B remained predominant in 2017; despite a 56.1% decrease over the 10-year period, the rate of decrease has slowed in recent years and varies by age group. Serogroup C was the second most prevalent serogroup until 2016. Its incidence decreased among individuals aged 1-24 years, the main population targeted by MenC vaccination campaigns, but increases have occurred in other age groups. Incidences of serogroups W and Y were low but increased by > 500% and > 130% (to 0.10 and 0.07/100,000) respectively, from 2008 to 2017. Considering all serogroups, a marked modification of the evolution trends by age group has occurred, with increases in incidence mainly affecting older age groups.ConclusionAlthough the overall IMD incidence decreased in Europe between 2008 and 2017, increases were observed for serogroups W and Y, and in the older population when considering all serogroups. It may be necessary to adapt current vaccination strategies to reflect epidemiological changes and their likely future evolution.
引用
- Nuttens C, Findlow J, Balmer P, et al. Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017. Euro Surveill. 2022. PMID: 35057902. doi:10.2807/1560-7917.ES.2022.27.3.2002075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。